Will the government launch a new customs integrated platform in two years?
Synopsis
The government is gearing up to unveil a groundbreaking Customs Integrated System (CIS) in the next two years. This innovative platform aims to streamline customs processes, enhance cargo clearance, and support exports, especially for fishermen. Discover how these changes will impact trade and healthcare in India.
Key Takeaways
Customs Integrated System to be launched in two years.
Seamless cargo clearance through a digital interface .
Advanced AI technology for risk assessment.
Support for Indian fishermen through new export measures.
Waiver of customs duties on essential medications .
New Delhi, Feb 1 (NationPress) The government is set to introduce a Customs Integrated System (CIS) within a two-year timeframe, creating a single, unified, and scalable platform for all customs operations, Finance Minister Nirmala Sitharaman announced on Sunday during the presentation of the Union Budget 2026-27.
The application of non-intrusive scanning utilizing cutting-edge imaging and AI technology for risk evaluation will be gradually implemented, ensuring that every container is scanned at all major ports, as stated in an official release.
By the end of the fiscal year, the approvals necessary for cargo clearance from various governmental bodies will be processed seamlessly through a single, interconnected digital interface, according to the Ministry of Finance.
The clearance processes for food items, pharmaceuticals, and animal and wildlife products—comprising approximately 70% of interdicted cargo—will be operational on this new system by April 2026, the minister indicated.
Additionally, goods that do not require compliance will receive immediate customs clearance once the importer completes online registration after duty payment.
The Finance Minister also highlighted that new export initiatives would assist Indian fishermen by exempting duty on fish caught by Indian vessels in the Exclusive Economic Zone or the High Seas and recognizing the landing of such fish at foreign ports as exports.
To mitigate misuse during the fishing, transit, and transshipment processes, safeguards will be established, as stated by Sitharaman.
The current value limit of Rs 10 lakh per consignment for courier exports will be lifted to empower India's small enterprises, artisans, and start-ups to reach global markets via e-commerce.
The management of rejected and returned consignments will also be enhanced through effective technological implementation to identify such shipments, she added.
Moreover, the government plans to abolish customs duties on 17 cancer medications and seven for rare diseases, as well as establish a second National Institute of Mental Health and Neurosciences (NIMHANS) in Northern India to enhance mental healthcare in the nation.
Point of View
The government is setting the stage for enhanced trade capabilities while also addressing critical healthcare needs through duty exemptions on essential medications. This forward-thinking approach aligns with India's vision of becoming a global economic player.
NationPress
1 May 2026
Frequently Asked Questions
What is the Customs Integrated System (CIS)?
The Customs Integrated System (CIS) is a proposed platform aimed at unifying all customs processes into a single, scalable system designed to enhance efficiency and transparency in cargo clearance.
When will the CIS be implemented?
The government plans to roll out the Customs Integrated System within the next two years, with significant phases of implementation outlined.
How will this affect Indian fishermen?
The CIS will provide new export measures that exempt duty on fish caught by Indian vessels, facilitating easier access to international markets.
What changes can we expect in cargo clearance?
Cargo clearance processes will be streamlined through a single digital window, allowing for quicker approvals from various government agencies.
Will customs duties be waived for any medications?
Yes, the government has proposed to waive customs duties on several medications, including drugs for cancer and rare diseases, to support healthcare initiatives.
